During the past decade, Caritas-Krankenhaus Bad Mergentheim conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Caritas-Krankenhaus Bad Mergentheim" #1 sponsor was "University of Medicine and Pharmacy Craiova" with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Aesculap AG" with 1 trials sponsored, "Biogen" with 1 trials sponsored and "German CLL Study Group" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Caritas-Krankenhaus Bad Mergentheim" #1 collaborator was "Caritas-Krankenhaus Bad Mergentheim" with 2 trials as a collaborator, "Glasgow Royal Infirmary" with 2 trials as a collaborator, "Institut Paoli-Calmettes" with 2 trials as a collaborator, "Odense University Hospital" with 2 trials as a collaborator and "University of Bergen" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Caritas-Krankenhaus Bad Mergentheim" are "Chronic Pancreatitis" (2 trials), "Adenocarcinoma Pancreas" (1 trials), "Brain and Central Nervous System Tumors" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Leukemia" (1 trials). Many other conditions were trialed in "Caritas-Krankenhaus Bad Mergentheim" in a lesser frequency.

Most popular intervention types in "Caritas-Krankenhaus Bad Mergentheim" are "Drug" (5 trials), "Device" (3 trials), "Procedure" (2 trials), "Radiation" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (2 trials), "5-FU" (1 trials), "5-FU and oxaliplatin" (1 trials), "Cytology (FNAB) or Surgery" (1 trials) and "Fludarabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Caritas-Krankenhaus Bad Mergentheim" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Caritas-Krankenhaus Bad Mergentheim". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Caritas-Krankenhaus Bad Mergentheim, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Caritas-Krankenhaus Bad Mergentheim, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".